Ensysce Biosciences (ENSC) News Today $3.12 -0.08 (-2.50%) Closing price 03/27/2025 03:59 PM EasternExtended Trading$3.18 +0.06 (+1.92%) As of 03/27/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Ensysce Biosciences Advances in Opioid InnovationMarch 19, 2025 | tipranks.comEnsysce Biosciences (ENSC) Projected to Post Quarterly Earnings on FridayMarch 19, 2025 | americanbankingnews.comEnsysce Biosciences announces PAINWeek 2025 SymposiumMarch 18, 2025 | msn.comENSC Starts 2025 in Great ShapeMarch 11, 2025 | msn.comEnsysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation OpioidsMarch 3, 2025 | prnewswire.comEnsysce Biosciences announces continued enrollment in PF614-MPAR trialFebruary 5, 2025 | markets.businessinsider.comWhen Can We Expect A Profit From Ensysce Biosciences, Inc. (NASDAQ:ENSC)?February 4, 2025 | finance.yahoo.comENSC Continues to Announce Potential Life-Changing ResultsJanuary 22, 2025 | msn.comEnsysce Biosciences announces interim data for PF614-MPARJanuary 22, 2025 | markets.businessinsider.comEnsysce Biosciences Inc.: Ensysce Biosciences Issues Annual Shareholder LetterJanuary 8, 2025 | finanznachrichten.deAnson Funds Management LP Buys New Stake in Ensysce Biosciences, Inc. (NASDAQ:ENSC)Anson Funds Management LP bought a new stake in shares of Ensysce Biosciences, Inc. (NASDAQ:ENSC - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 983,518 shares of the company's stock, valued at approximately $236,000. AnsonDecember 8, 2024 | marketbeat.comEnsysce Biosciences Inc.: Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR TrialNovember 26, 2024 | finanznachrichten.deEnsysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR TrialNovember 26, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences Reports Third Quarter 2024 Financial ResultsNovember 13, 2024 | finanznachrichten.deENSC Improves PositionNovember 13, 2024 | msn.comEnsysce Biosciences Reports Improved Financial ResultsNovember 13, 2024 | markets.businessinsider.comEnsysce Biosciences receives extension to demonstrate Nasdaq complianceNovember 8, 2024 | markets.businessinsider.comEnsysce Biosciences Announces Leadership Team’s Participation in the Annual Pain Therapeutics SummitOctober 8, 2024 | finance.yahoo.comWhy Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving PremarketSeptember 30, 2024 | benzinga.comEnsysce Biosciences, Inc.: Ensysce Biosciences Submits Phase 3 Protocol to the FDASeptember 19, 2024 | finanznachrichten.deEnsysce Biosciences, Inc.: Ensysce Biosciences Announces IRB Approval for Key MPAR StudyAugust 27, 2024 | finanznachrichten.deBiotech Steals The Show Following $14 Million Grant AnnouncementAugust 27, 2024 | theglobeandmail.comEnsysce Biosciences, Inc.: Ensysce Biosciences Receives $14 Million NIH Grant for Clinical Development of Novel Opioid with Overdose ProtectionAugust 27, 2024 | finanznachrichten.deENSC Treatment Gets Substantial GrantAugust 27, 2024 | msn.comDiamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)August 23, 2024 | globenewswire.comEnsysce Biosciences, Inc.: Ensysce Biosciences Reports Second Quarter 2024 Financial ResultsAugust 15, 2024 | finanznachrichten.deENSC Furthers Important Drug ResearchAugust 15, 2024 | msn.comEnsysce Biosciences, Inc.: Ensysce Biosciences Provides Key Themes Following IASP 2024 SymposiumAugust 8, 2024 | finanznachrichten.deEnsysce Biosciences, Inc. (NASDAQ:ENSC): Are Analysts Optimistic?August 3, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences Provides Mid-Year 2024 UpdateJuly 24, 2024 | finanznachrichten.deENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024June 24, 2024 | investorplace.comSector Update: Health Care Stocks Softer Late AfternoonMay 20, 2024 | finance.yahoo.comEnsysce Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagMay 14, 2024 | finance.yahoo.comENSC: Quarterly Report Highlights ProgressMay 13, 2024 | msn.comEnsysce Biosciences, Inc.: Ensysce Biosciences' CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge MagazineApril 25, 2024 | finanznachrichten.deEnsysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge MagazineApril 25, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceApril 9, 2024 | finanznachrichten.deENSC Stock Earnings: Ensysce Biosciences Misses EPS, Beats Revenue for Q4 2023March 18, 2024 | investorplace.comENSC Striding Toward Opioid ReplacementMarch 15, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 15, 2024 | finanznachrichten.deEnsysce Biosciences Stock (NASDAQ:ENSC), Short Interest ReportFebruary 21, 2024 | benzinga.comEnsysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose ProtectionFebruary 21, 2024 | finance.yahoo.comENSC: Investors Should Pay AttentionFebruary 16, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences Announces Publication of Clinical Bioequivalence ManuscriptFebruary 15, 2024 | finanznachrichten.deEnsysce Biosciences Announces Publication of Clinical Bioequivalence ManuscriptFebruary 15, 2024 | finance.yahoo.comEnsysce Biosciences falls on exercise of warrants for $4.7M gross proceedsFebruary 13, 2024 | msn.comEnsysce Biosciences, Inc. Announces Exercise of Warrants for $4.7 Million Gross ProceedsFebruary 13, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences Selected to Present at American Association of Pain Medicine Annual ConferenceFebruary 6, 2024 | finanznachrichten.deEnsysce Biosciences Selected to Present at American Association of Pain Medicine Annual ConferenceFebruary 6, 2024 | finance.yahoo.comEnsysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe PainJanuary 31, 2024 | finance.yahoo.com Remove Ads Get Ensysce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter. Email Address ENSC Media Mentions By Week ENSC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENSC News Sentiment▼1.440.79▲Average Medical News Sentiment ENSC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENSC Articles This Week▼20▲ENSC Articles Average Week Remove Ads Get Ensysce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CGTX News LSTA News LPCN News ME News CLDI News EGRX News INAB News MTEX News CLRB News SNTI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENSC) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENSC Stock Free ENSC Stock Alerts